Phenobarbital Global Buyers List: Market Trends, Key Suppliers, and Sourcing Strategies
Introduction to Phenobarbital’s Global Significance
Phenobarbital, a barbiturate-derived anticonvulsant, remains a critical medication for managing epilepsy and neonatal seizures worldwide. Its utility spans decades, but recent advancements—such as benzyl alcohol and propylene glycol-free formulations—have revitalized its relevance in modern therapeutics. The global market for Phenobarbital is characterized by steady demand, particularly in regions with high incidences of epilepsy and limited healthcare infrastructure. This article provides a detailed analysis of key buyers, suppliers, regulatory developments, and sourcing strategies, offering stakeholders a roadmap to navigate this specialized pharmaceutical segment. With innovations like Sun Pharma’s Sezaby injection gaining FDA approval, the market is poised for strategic shifts, emphasizing safety and accessibility .
Key Global Buyers and Procurement Channels
The demand for Phenobarbital is driven by diverse stakeholders, including hospital networks, government health agencies, and specialized pharmaceutical distributors. Neonatal intensive care units (NICUs) in the U.S. represent a growing buyer segment following the 2022 FDA approval of Sezaby, the first phenobarbital injection specifically indicated for seizures in term and preterm infants. This has positioned U.S. hospitals as priority buyers, leveraging Sun Pharma’s established distribution networks . In emerging markets, such as parts of Asia and Africa, procurement is often centralized through national health programs or NGOs addressing epilepsy treatment gaps. For instance, Pharmanovia’s acquisition of Sanofi’s CNS portfolio—including Gardenal® (Phenobarbital)—has expanded its commercial reach to over 60 countries, targeting buyers in Brazil, South Africa, and France . Additionally, generic suppliers like Vietnam’s Khánh Hòa Pharmaceutical Company cater to cost-sensitive buyers in Southeast Asia, offering oral tablets at competitive prices .
Major Suppliers and Market Innovations
The supply landscape is dominated by established players with specialized formulations and regulatory approvals. Sun Pharma Advanced Research Company (SPARC) and its commercial partner Sun Pharma lead innovation with Sezaby, a formulation designed to minimize the risk of neonatal gasping syndrome by excluding benzyl alcohol and propylene glycol. This product, which received orphan drug designation from the FDA, targets a previously unaddressed niche and underscores the industry’s shift toward safer pediatric therapeutics . Meanwhile, Pharmanovia’s acquisition of Sanofi’s CNS brands like Gardenal® has strengthened its neurology franchise, enabling it to supply Phenobarbital to markets in Europe and Latin America . Generic manufacturers, such as India’s Sedonal and Shinosun producers, focus on oral tablets and injectables for broad-based demand, though they face competition from benzodiazepines in anxiety-related applications . Innovations in drug delivery and regulatory compliance are becoming key differentiators, as seen in SPARC’s tiered royalty model with Sun Pharma, which includes upfront payments and milestone-based incentives .
Regulatory and Market Trends Shaping Demand
Regulatory approvals and safety guidelines heavily influence sourcing decisions. The FDA’s 2022 endorsement of Sezaby set a precedent for stringent excipient standards, prompting buyers to prioritize formulations that reduce risks like gasping syndrome in neonates . In regions like Australia, Phenobarbital is classified as a Schedule IV controlled substance due to misuse concerns, leading to tighter prescription controls and a decline in its use for anxiety in favor of benzodiazepines . Market trends also highlight growing demand for emergency-use formulations; for example, Phenobarbital injections are increasingly stocked in ambulances and ICUs for status epilepticus management. Economically, emerging markets drive volume growth, while developed regions focus on premium, specialized products. Analysts project a steady CAGR of 3–5% through 2028, with China and India leading production capacity expansions .
Strategic Sourcing Insights for Buyers
Procuring Phenobarbital requires balancing cost, quality, and regulatory compliance. Buyers should prioritize suppliers with FDA- or EMA-approved facilities to ensure adherence to Good Manufacturing Practices (GMP). For institutional procurement, partnering with authorized distributors like Sun Pharma—which offers hospital-specific logistics—can guarantee supply chain integrity . Key considerations include:
- Formulation Selection: Benzyl alcohol-free injections are critical for neonatal use, while oral tablets suffice for chronic epilepsy in adults .
- Geographic Factors: In the U.S., Sezaby’s Q4 2023 launch timeline informed inventory planning, whereas in Europe, Pharmanovia’s Gardenal® dominates .
- Pricing Trends: Generic tablets cost 0.10–0.50 per dose in bulk, while innovative formulations like Sezaby command premium pricing .Buyers must also monitor regulatory updates, such as the WHO’s essential medicines list, which affirms Phenobarbital’s role in resource-limited settings .
ООО GRAND PHARM TRADE
SIEMENS HEALTHCARE PRIVATE LIMITED
ООО FARM LYUKS INVEST
PAR FORMULATIONS PRIVATE LIMITED
ZOETIS PHILIPPINES INC
ООО CURATIO PHARM
CHROMACHEMIE LABORATORY PRIVATE LIMITED
ABBOTT LABORATORIES DE COLOMBIA SA
ROCHE ECUADOR S A
OOO GENESIS PHARMA
ORTHO CLINICAL DIAGNOSTICS PHIL INC
OOO FARM LYUKS INVEST
ZOETIS S R L
BECKMAN COULTER INDIA PRIVATE LIMITED
EVERON LIFE SCIENCES
ZOETIS MEXICO S DE RL DE CV
KAUSTUBHA SCIENTIFIC RESEARCH LABORATORYPRIVATE LI
PRODS ROCHE S A
ERNEST CHEMISTS LIMITED
G T SCIENTIFIC S A
OOO MEMORY PHARM A G
ROCHEM BIOCARE DEL PERU S A C
ООО HURSHIDA ENTER DELUX
GPNC
MEDECINS SANS FRONTIERES
ТОО ИНВИТРО КАЗАХСТАН
PHILUSA CORP
ZETA PHARMACEUTICALS LLC
ИП ООО ASKLEPIY
ООО XASAN XUSAN FARM
CADILA PHARMACEUTICALS LIMITED
JOINT MEDICAL STORE UPMB UCMB
LABORATORY AND ALLIED LIMITED
MEDVIN PHARMA LIMITED
ASTRA PHARMA U LIMITED
INDEX SACI
KOPRAN LABORATORIES LIMITED
SISTEMAS ANALITICOS SRL
INCEPTA PHARMACEUTICALS LIMITED
DAWA LIMITED
REPRESENTACIONES MEDICAS DEL PERU S R L
SUN PHARMACEUTICAL MEDICARE LIMITED
VENUS PHARMA
COSMOS LIMITED
OOO BIOTEK FARM
OOO GRAND PHARM TRADE
OOO MEROS PHARM
PT MERSIFARMA TIRMAKU MERCUSANA
STATE PHARMACEUTICALS CORPORARION
ООО PHARMAXI
ТОВ КОМПАНІЯ ВІННЕР ТРЕЙД УКРАЇНА 49027 МІСТО ДНІПРО ВУЛ АКІНФІЄВА ІВАНА 18 ОФІС ГЗ01
ABBOTT LABORATORIES VENICE CORPORATE CENTER
BLUE HEALTH INTERNATIONAL ECUADOR S A S
ISSGF INDIA PVT LTD
SIMED S A
SUIZA VET S A C
UNKNOWN
ЧП BEK BARAKA SAMARQAND IK
ABBOTT LABORATORIES DE MEXICO SA DE CV
DIAGNOSTICA PERUANA S A C
ETHIOPIAN PHARMACEUTICALS MANUFACTU
GARMONIYA FARM ООО
LABORATORIOS BETA SOCIEDAD ANONIMA
MARSMAN DRYSDALE MEDICAL PRODUCTS
MEDIATE PHARMACEUTICAL PVT LTD
MINISTRY OF HEALTH OF GHANA
PENANSHIN SHIPPING THAILAND LTD
SHAHEEN PHARMACEUTICALS
UNICOM CHEMIST LIMITED
ООО JAMXUR PHARM SERVIS
ТОО DPB NEW BRANDS
AMASS GLOBAL NETWORK US INC
BRISTOL LABORATORIES LTD
CÔNG TY CỔ PHẦN DƯỢC DANAPHA
CÔNG TY TNHH VẬT TƯ KHOA HỌC CÔNG NGHỆ T T
G2 PHARMACY
HARMAN FINOCHEM LIMITED
JOINT MEDICAL STORE UPMB UCMB KAMPALA MAKINDYE DIVISION WEST MAKINDYE DIVISION NSAMBYA ESTATE GOGONYA RD
KINAPHARMA LIMITED
LABORATORIOS UNIDOS S A
MACARTHYS LABORATORIES LTD
MEDECINS SANS FRONTIERES FRANCE
MEDECINS SANS FRONTIERS SWITZERLAND
MEDIATE PHARMACEUTICAL PVT LIMITED
MERCK INC
OMC LIMITED CHANGE FROM OVERSEAS
OOO YOUNG PHARM
OPSONIN PHARMA LIMITED
PROVEEDORA QUIMICO FARMACEUTICA SA DE CV
PT ACTAVIS INDONESIA
SECURITY FORENSIC ENTERPRISES INC
ACTAVIS INDONESIA
ACTIVE PHARMA SUPPLIES LTD
ADDIS PHARMACEUTICAL FACTORY SHARE
ARENA PHARMACEUTICALS LTD
AZELIS UK LIMITED
BAYER TURK KIMYA SANLTD STI
BELGIUM
BIODEAL LABORATORIES LIMITED
BOLLORE TRANSPORT LOGISTICS DJIBOU
CALIBER CARGO LOGISTICS INC
CERP REUNION SAS
CHR OLESEN PHARMACEUTICALS A S
CINCHONA BIOSCIENCES
CLINIQUE SAINTE CLOTILDE
CRISTALIA PRODUTOS QUIMICOS FARMACEUTICOS LTDA
CÔNG TY CỔ PHẦN DƯỢC PHẨM KHÁNH HÒA
CÔNG TY TNHH THƯƠNG MẠI H B C
DACHSER TRANSPORT LOGISTICS
DROGUERIA LIBERTAD SA
FEROZSONS LABORATORIES LIMITED
FEROZSONS LABORATORIES LTD
GREENCROSS EXPORT PRIVATE LIMITED
HUMANWELL PHARMACEUTICAL ETHIOPIA P
INDUFAR COMERCIAL E INDUSTRIAL SA
KAMPALA PHARMACEUTICAL INDUSTRIES 1996 LIMITED
M S MBL PHARMA
M S RASCO PHARMA
M S UNIVERSAL PHARMACEUTICALS PVT LTD
MARSMAN DRYSDALE MEDICAL PRODUCTS INC
MBL PHARMA
MEDECINS SANS FRONTIERES KAMPALA MAKINDYE DIVISION EAST MAKINDYE DIVISION KANSANGACHURCH NSAMBYA HANLON
ONG COMMUNAUTE SAINT CAMILLE DE LELL
PLIVA PAKISTAN PVT LIMITED
PLIVA PAKISTAN PVT LTD
PT ABBOTT PRODUCTS INDONESIA
PT KIMIA FARMA TBK
PT PHAPROS TBK
RANDOX LABORATORIES INDIA PRIVATE LIMITED
RAPTIM RESEARCH PRIVATE LIMITED
ROSPAW SRL
SANOFI MEDLEY FARMACEUTICA LTDA
SAS UNIPHARMA
SIGMA ALDRICH COMPANY LTD
SOBAPS SA
SUCOPEIA REFERENCESTANDARDS OPC PRIVATE LIMITED
TAPE RUVICHA SA EMISORA DE CAPITAL ABIERTO
TRANS GLOBE PHARMACEUTICAL COMPANY LTD
VEEDA CLINICAL RESEARCH LIMITED
VENOR PHARMA LIMITED
VIMTA LABS LIMITED
WESSEX FINE CHEMICALS LIMITED
XENON PHARMACEUTICALS PVT LIMITED
XENON PHARMACEUTICALS PVT LTD
YADEN LABORATORIES PVT LTD
АК ДОРИ ДАРМОН
АТ ФАРМАК УКРАЇНА 04080 М КИЇВ ВУЛ КИРИЛІВСЬКА 63
ООО DELPHARM
ООО KAMALAK S
ООО MAGNA MANAGING GROUP
ООО PHARMA CHOICE
ООО УЗБЕКИСТОН ДОРИ ТАЪМИНОТИ
СП ООО AZIA METALL PROF
ТОВ ІСТФАРМА ПРOВ КРИНИЧНИЙ 10 61022 М ХАРКІВ УКРАЇНА
ТОВ ДІАМЕДІХ ІМПЕХ
ТОВ ДІАМЕДІХ ІМПЕХ УКРАЇНА 01054 МІСТО КИЇВ ВУЛИЦЯ ПАВЛІВСЬКА БУДИНОК 17 ІНШЕ ПІД ЗД
ABBOTT LABORATORIES PAKISTAN LIMITED
ACI GROUP LTD
ACME GENERICS PRIVATE LIMITED
AE ALCHEMISTS INC
ARIES PHARMACEUTICAL PRIVATE LIMITED
ARIES PHARMACEUTICALS PVT LTD
BEA MOUNTAIN MINING COMP
BIOGENUIX MEDSYSTEMS PRIVATE LIMITED
BUNTY PHARMACEUTICALS
CAMP FIRE INVESTMENTS PROPRIETARY LIMITED
CENTRE HOSPITALIER OUEST REUNION
CHEMO CENTROAMERICANA SOCIEDAD ANONIMA
CHU DE LA REUNION
CLOVER CHEMICAL INDUSTRIES PTY LTD
COMET HEALTHCARE LTD
CORIS BANK INTERNATIONAL SA
CUSTOM HEALTHCARE LTD
CÔNG TY CỔ PHẦN DƯỢC PHẨM TRUNG ƯƠNG CPC1
CÔNG TY CỔ PHẦN DƯỢC PHẨM TRUNG ƯƠNG VIDIPHA
CÔNG TY CỔ PHẦN THƯƠNG MẠI VÀ SẢN XUẤT THUỐC THÚ Y THỊNH Á
CÔNG TY CỔ PHẦN VẬT TƯ KỸ THUẬT ĐÔNG DƯƠNG
CÔNG TY TNHH THIẾT BỊ Y TẾ PHƯƠNG ĐÔNG
CÔNG TY TNHH VẬT TƯ KHOA HỌC KỸ THUẬT ĐÔNG DƯƠNG
EL BC SUPPLY SA DE CV
ETNA LABORATUVAR COZUMLERI SANAYI TICARET LIMITED SIRKETI
FAGRON UK LTD
FEROZSONS LABORATRIES LIMITED
FUNDACAO PARA O REMEDIO POPULAR FURP
GEKA PHARMA PTY LTD
GENERICS AFRICA LIMITED
GENPORT LABORATUVAR URUNLERI SANAYI VE TICARET LIMITED SIRKETI
GROUPE HOSPITALIER EST REUNION
GYMA LABORATORIES OF AMERICA INC
IKARUS VETERINER VE PET URUNLERI SANAYI VE TICARET LIMITED SIRKETI
IMMENSE CORPORATION GROUP CO LTD
INTERLAB LABORATUAR URUNLERI SANAYI VE TICARET ANONIM SIRKETI
KAIROS INDUSTRIAL CHEMICALS PROPRIETARY LIMITED
LABORATORIO RAVEN S A
LABORATORIO RAVEN SOCIEDAD ANONIMA
LAS DO BRASIL COMERCIO DE PRODUTOS ANALITICOS E LABORATORIAIS LTDA
M S FEROZSONS LABORATORIES LTD
M S MEDICRAFT PHARMACEUTICAL PVT LTD
M S MEDICRAFT PHARMACEUTICALS PVT LTD
M S RORYAN PHARMACEUTICAL INDUSTRIES PVT LTD
M S SHAHEEN PHARMACEUTICALS
M S XENON PHARMACEUTICALS PVT LTD
MAWDSLEY BROOKS COMPANY
MCD PHARMA S A S
MEDECINES SANS FRONTIERES FRANCE
MEDECINES SANS FRONTIERS SWITZERLAND
MEDICAL STORES DEPARTMENT
MEDIMARKER S LABORATORIES PVT LTD
MEDIMARKERS LABORATORIES PVT LTD
MEDLAB BOLIVIA LTDA
MEDREICH LIMITED
MS SHAHEEN PHARMACEUTICALS
MSF SOMALIA C O MSF HOLLAND
MUREX DIAGNOSTIC PRODUCTS SPECIALISTS
OOO ASTOR ALLIANCE
ORTHO CLINICAL DIAGNOSTICS
OVERSEAS MARKETING CORPORATION PRIVATE LIMITED
PFIZER ANIMAL HEALTH MEXICO S DE R L DE C V
PHARMAFFILIATES PRIVATE LIMITED
PT IMCD INDONESIA
PT ZOETIS ANIMALHEALTH INDONESIA
QWINJAYA ADITAMA PT
RADIANCE PHARMACEUTICALS LIMITED
RAKS PHARMA PRIVATE LIMITED
RASCO PHARMA
RASCO PHARMA PVT LTD
RIPPLE PHARMACEUTICALS LIMITED
ROCA POOL SPA SP Z O O
RORYAN PHARMACEUTICAL INDUSTRIES PVT LTD
SAYYED PHARMACEUTICAL PVT LTD
SAYYED PHARMACEUTICLA INDUSTRIES PRIVATE LIMITED
SCAVONE HERMANOS SA
SIEMENS HEALTHCARE EQ MED SPA
SIEMENS HEALTHCARE S A S
SIROCCO PROPRIETARY LIMITED
STE PHARMASPRESS SARL
SUNTRANS
SYNGENE SCIENTIFIC SOLUTIONS LIMITED
TCS PVT LIMITED
TEVA LLC TRADE
UNICEF
UNITED NATIONS CHILDREN S FUND AFGHANISTAN COUNTR
UNITED NATIONS HIGH COMMISIONER FO
UNITED NATIONS HIGH COMMISIONER FO KAMPALA KAMPALA CENTRAL DIVI KAM KOLOLO IMACKENZIE KOLOLO MACKENZIE CLOSE UNHCR 11 13 11 13 KAMPALA
UNIVERSAL PHARMACEUTICALS PVT LTD
VETS AND PETS TRAIDING COLOMBIA S A S
WILSHIRE LABORATRIES PRIVATE LIMITED
WILSHIRE LABS PVT LTD
WORLD HEALTH ORGANIZATION
YADEN INTERNATIONAL PVT LTD
ZAIN PHARMA LIMITED
ZAMMSA
ZANAK PHARMACEUTICALS
ZOETIS ANIMALHEALTH INDONESIA
ZOETIS COLOMBIA SAS
АКЦІОНЕРНЕ ТОВАРИСТВО ФАРМАК 04080 М КИЇВ ВУЛ КИРИЛІВСЬКА 63
АТ КИЇВСЬКИЙ ВІТАМІННИЙ ЗАВОД 04073 ВУЛ КОПИЛІВСЬКА 38 М КИЇВ
АТ ФАРМАК
МЧЖ MEROS PHARM
ОАО ФАРМСТАНДАРТ ЛЕКСРЕДСТВА
ООО DRUG PROMOTION
ООО MEROS PHARM
ТОВ ІСТФАРМА ПРОВ КРИНИЧНИЙ 10 61022 М ХАРКІВ УКРАЇНА
ТОВ ДІАМЕДІХ ІМПЕХ УКРАЇНА 01054 МІСТO КИЇВ ВУЛИЦЯ ПАВЛІВСЬКА БУДИНOК 17 ІНШЕ ПІД ЗД
ТОВ КОМПАНІЯ ВІННЕР ТРЕЙД
ТОВ ФАРМА СТАРТ 03124 М КИЇВ Б Р В ГАВЕЛА 8
ТОО SMARTCHEM
ТОО ТЕХНОКОМ ГРУПП
Conclusion: Navigating the Future of Phenobarbital Procurement
The Phenobarbital market is evolving toward safer, targeted formulations, with partnerships like Sun Pharma-SPARC setting new benchmarks for neonatal care. Global buyers must align with certified suppliers, leverage regional regulatory insights, and prioritize patient safety in sourcing strategies. As demand grows in emerging economies and innovation continues, stakeholders can capitalize on structured partnerships and data-driven market analyses to optimize their procurement approaches .
